t
Piper Jaffray Raises Price Target on ISIS Pharmaceuticals (ISIS)
July 18th, 2012 - 0 comments - Filed Under - by Patrick Bannon
ISIS Pharmaceuticals, Inc. logoInvestment analysts at Piper Jaffray lifted their target price on shares of ISIS Pharmaceuticals (NASDAQ: ISIS) from $15.00 to $18.00 in a note issued to investors on Wednesday. The firm currently has an “overweight” rating on the stock.
The analysts wrote, “ISIS is the leading antisense company with a rich pipeline of drugs in development. The primary driver for ISIS shares remains KYNAMRO with European approval this year and a January 29, 2013 PDUFA date. While ISIS shares have risen considerably since May 1st, we look for continued upside driven by KYNAMRO approval, clinical data read-outs and new partnerships. ISIS remains a Top Pick for 2H:12.”
Shares of ISIS Pharmaceuticals traded up 1.67% during mid-day trading on Wednesday, hitting $13.97. ISIS Pharmaceuticals has a 52 week low of $6.25 and a 52 week high of $14.01. The company’s market cap is $1.400 billion.
ISIS Pharmaceuticals last issued its quarterly earnings data on Tuesday, May 8th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.04. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. On average, analysts predict that ISIS Pharmaceuticals will post $-0.79 earnings per share for the current fiscal year.
A number of other firms have also recently commented on ISIS. Analysts at Zacks reiterated a “neutral” rating on shares of ISIS Pharmaceuticals in a research note to investors on Tuesday, July 10th. They now have a $15.00 price target on the stock. Separately, analysts at Needham & Company initiated coverage on shares of ISIS Pharmaceuticals in a research note to investors on Tuesday, May 22nd. They set a “buy” rating and a $14.00 price target on the stock.
Isis Pharmaceuticals, Inc. (Isis) is engaged in antisense technology, exploiting a drug discovery platform created to generate first-in-class drugs.
- Forums
- ASX - By Stock
- PER
- isis flying.anp fueling up.
isis flying.anp fueling up.
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.5¢ |
Change
0.001(1.35%) |
Mkt cap ! $67.61M |
Open | High | Low | Value | Volume |
7.7¢ | 7.8¢ | 7.4¢ | $24.63K | 325.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 142779 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 8181 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 142779 | 0.073 |
2 | 147362 | 0.072 |
2 | 310000 | 0.071 |
4 | 34299 | 0.070 |
2 | 28980 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 8181 | 1 |
0.078 | 125476 | 3 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
0.081 | 125000 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |